ClearLine MD LLC is a medical device company founded and funded by forward-thinking device engineers based on first-hand knowledge of an avoidable adverse event, air embolism. The Company is focused on the development and commercialization of fluid management devices that advance operational safety and protect patients against the dangerous intrusion of air during vascular access.
The Company’s ClearLine IV system prevents the introduction of air into the vascular system during IV infusion by detecting air in the IV line using ultrasound technology. The device then removes the air, enabling the continuous flow of fluid. Now clinicians can deliver fluids, medication, blood or blood products using an intravenous or central line with peace of mind that only the intended fluid is reaching the patient. ClearLine IV protects patients against the dangerous intrusion of air through IV lines and long-term clinical complications, extended hospital stays and medical liability costs associated with air embolisms. ClearLine IV is the only FDA-cleared and CE certified device for the automatic detection and removal of air from fluid lines.
ClearLine MD is delivering a new standard of care for eliminating air from IV lines and avoiding the costly clinical complications associated with air embolisms.